SAN FRANCISCO, CA—August 19, 2009—The J. David Gladstone Institutes announced a collaboration with Alitora Systems to develop software technology that facilitates organizational collaboration and enables rapid acceleration of the discovery and evaluation of new drugs.
Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Julie Langelier, Science Writer and Public Relations Specialist
Direct line: 415.734.5000
Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019
SAN FRANCISCO, CA, August 14, 2009—The Gladstone Institute of Neurological Disease (GIND) announced that Dena Dubal, MD, PhD has been named a Beeson scholar for her research into Alzheimer's disease.
SAN FRANCISCO, CA—August 11, 2009—Investor and philanthropist William S. Price III and his wife, Eva, have donated $4.25 million to fund biomedical research programs at The J. David Gladstone Institutes.
SAN FRANCISCO, CA—July 5, 2009—Researchers at the Gladstone Institute of Cardiovascular Disease (GICD) have discovered a key switch that makes stem cells turn into the type of muscle cells that reside in the wall of blood vessels.
SAN FRANCISCO, CA–June 25, 2009–Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found another clue that may lead to eradication of HIV from infected patients who have been on antiretroviral therapy.
SAN FRANCISCO, CA—April 26, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD)have identified for the first time key genetic factors that drive the process of generating new heart cells.
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institutes and Kyoto University is one of seven recipients of Canada's prestigious Gairdner Award. The Gairdner is referred to as the “Baby Nobel,” since many winners then go on to win the Nobel Prize.
SAN FRANCISCO, CA—March 25, 2009—The J. David Gladstone Institutes has joined forces with Taube Philanthropies and the Koret Foundation to initiate a groundbreaking research program aimed at preventing, treating, or curing Huntington's disease (HD) by the year 2020.
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes of Cardiovascular Disease (GICD) have found that a key enzyme involved in absorbing fat may also be a key to reducing it.
SAN FRANCISCO, CA—The J. David Gladstone Institutes announced that it has received a major grant from the W.M. Keck Foundation in Los Angeles to establish the Keck Program for Striatal Physiology and Pathophysiology, which will study the origins of movement disorders associated with neurological diseases such as Parkinson's and Huntington's diseases.